Anna Fabiano

500 total citations
7 papers, 132 citations indexed

About

Anna Fabiano is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, Anna Fabiano has authored 7 papers receiving a total of 132 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Genetics and 2 papers in Surgery. Recurrent topics in Anna Fabiano's work include Virus-based gene therapy research (3 papers), CRISPR and Genetic Engineering (3 papers) and Viral gastroenteritis research and epidemiology (1 paper). Anna Fabiano is often cited by papers focused on Virus-based gene therapy research (3 papers), CRISPR and Genetic Engineering (3 papers) and Viral gastroenteritis research and epidemiology (1 paper). Anna Fabiano collaborates with scholars based in Italy, France and Germany. Anna Fabiano's co-authors include Giulia Pavani, Annarita Miccio, Mario Amendola, Jean‐Paul Concordet, Giuliana Ferrari, Fatima Amor, Giulia Maule, Fulvio Mavilio, Anne Chalumeau and Anna Cereseto and has published in prestigious journals such as Nature Communications, Cell Reports and Atherosclerosis.

In The Last Decade

Anna Fabiano

7 papers receiving 129 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Fabiano Italy	4	90	49	31	19	15	7	132
Guillaume Jedraszak France	7	53 0.6×	62 1.3×	26 0.8×	18 0.9×	12 0.8×	26	147
Mégane Brusson France	9	155 1.7×	54 1.1×	124 4.0×	64 3.4×	52 3.5×	17	227
Jason Fixler United States	5	152 1.7×	33 0.7×	52 1.7×	43 2.3×	5 0.3×	9	223
K. Chu United States	3	181 2.0×	147 3.0×	15 0.5×	31 1.6×	4 0.3×	3	229
Kazuko Kudo Japan	5	69 0.8×	12 0.2×	12 0.4×	44 2.3×	13 0.9×	7	107
Christopher R. Reilly United States	4	57 0.6×	20 0.4×	22 0.7×	37 1.9×	5 0.3×	10	122
Jiaoyang Liao China	7	168 1.9×	67 1.4×	51 1.6×	21 1.1×	1 0.1×	12	219
Rita Consolini Italy	3	55 0.6×	65 1.3×	24 0.8×	56 2.9×	6 0.4×	5	196
Sushree Sangita Sahoo United States	6	35 0.4×	40 0.8×	39 1.3×	91 4.8×	6 0.4×	13	136
William Zabala Venezuela	8	30 0.3×	52 1.1×	5 0.2×	11 0.6×	8 0.5×	18	114

Countries citing papers authored by Anna Fabiano

Since Specialization

Citations

This map shows the geographic impact of Anna Fabiano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Fabiano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Fabiano more than expected).

Fields of papers citing papers by Anna Fabiano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Fabiano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Fabiano. The network helps show where Anna Fabiano may publish in the future.

Co-authorship network of co-authors of Anna Fabiano

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Fabiano. A scholar is included among the top collaborators of Anna Fabiano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Fabiano. Anna Fabiano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Volpin, Monica, Anna Fabiano, Mauro Biffi, et al.. (2025). Enhancing the potency of in vivo lentiviral vector mediated gene therapy to hepatocytes. Nature Communications. 16(1). 4802–4802. 1 indexed citations

2.

Fabiano, Anna, Stefano Beretta, Tiziana Plati, et al.. (2025). Identification of hepatocyte-primed cholangiocytes in the homeostatic liver by in vivo lentiviral gene transfer to mice and non-human primates. Cell Reports. 44(3). 115341–115341. 2 indexed citations

3.

Merlin, Simone, Ester Borroni, Mauro Biffi, et al.. (2024). GP64-pseudotyped lentiviral vectors target liver endothelial cells and correct hemophilia A mice. EMBO Molecular Medicine. 16(6). 1427–1450. 7 indexed citations

4.

Fabiano, Anna, et al.. (2024). Low-density lipoproteins receptor (LDLR) liver gene therapy normalizes LDL cholesterol (LDL-C) and prevents atherosclerosis in a familial hypercholesterolemia (FH) mouse model. Atherosclerosis. 395. 118281–118281. 1 indexed citations

5.

Pavani, Giulia, Anna Fabiano, Fatima Amor, et al.. (2021). Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells. Blood Advances. 5(5). 1137–1153. 60 indexed citations

6.

Pavani, Giulia, Anna Fabiano, Guillaume Corre, et al.. (2020). Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins. Nature Communications. 11(1). 3778–3778. 33 indexed citations

7.

Rubini, Michele, Roberto Brusati, G. Garattini, et al.. (2005). Cystathionine beta-synthase c.844ins68 gene variant and non-syndromic cleft lip and palate. American Journal of Medical Genetics Part A. 136A(4). 368–372. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact